跳至主要内容
临床试验/CTIS2023-509575-16-00
CTIS2023-509575-16-00进行中(未招募)1 期

ow-Intervention Clinical Trial Evaluating a Novel Cytokine Release Assay for Tick-Borne Encephalitis (TBE) Among Healthy and Immunosuppressed Research Participants - 2023-509575-16-00

Vaestra Goetalandsregionen0 个研究点目标入组 100 人开始时间: 2024年2月12日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • The subject has given their written consent to participate in the clinical trial., Male and female research participants above or equal to 18 years of age.

排除标准

  • Women with ongoing pregnancy or breast feeding without prior history of hospitalization for TBE or vaccination against TBEV., Inability or unwillingness to provide informed consent or abide by the requirements of the clinical trial., Evidence of allergy or other known adverse reaction to components are part of the TBE vaccine (FSME-IMMUN Vuxen) for unvaccinated participants planning to undergo vaccination against TBEV in the clinical trial., Having a bleeding disorder or receiving preventive anticoagulation therapy which prevents the vaccine being administered intramuscularly, for individuals without prior history of hospitalization for TBE or prior vaccination against TBEV.

研究者

发起方
Vaestra Goetalandsregionen

相似试验